Clinical Trial Update: Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial of solifenacin succinate vs placebo in inner-city women with overactive bladder was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urge Incontinence

Drugs mentioned

• Vesicare (solifenacin succinate)

Snippet

Sponsor: Stamford Hospital | Conditions: Urinary Urge, Urge Incontinence | Phase 4 | Status: WITHDRAWN